June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Dengue cases surge by nearly 50% in Americas amid 'emergency situation', UN agency says

Published 04/18/2024, 12:28 PM
Updated 04/18/2024, 01:41 PM

MEXICO CITY (Reuters) - Dengue cases have created an "emergency situation" in the Americas, although cases in hotspots Argentina and Brazil appear to have stabilized, the head of the Pan American Health Organization (PAHO) said on Thursday.

PAHO, a United Nations agency, has confirmed more than 5.2 million cases of dengue across the Americas this year, an over 48% jump from the 3.5 million cases the group reported late last month.

More than 1,800 people have died from the mosquito-borne viral illness, up from over 1,000 deaths reported last month in the year through March.

"We have an emergency situation," PAHO Director Jarbas Barbosa said in a press briefing.

The countries so far hit the hardest in the current outbreak, Argentina and Brazil, "still have a very strong transmission," Barbosa said, adding that "in recent weeks there seems to be a stabilization, or even a reduction" in the countries' cases.

Barbosa warned that supply of an existing dengue vaccine is "very limited" and even widespread vaccination would not have an immediate impact on interrupting the ongoing outbreak.

© Reuters. FILE PHOTO: An Aedes aegypti mosquito with the dengue-blocking Wolbachia bacteria is seen at a laboratory in the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil April 9, 2024. REUTERS/Pilar Olivares

"The dengue vaccine can play an important role in reducing severe cases of deaths, but it will take time until the effects of the vaccine can be reflected in the decrease in dengue cases," Barbosa said.

Dengue symptoms include fever, headaches, vomiting, skin rashes, as well as muscle and joint pain. In some cases, it can cause a more severe hemorrhagic fever, resulting in bleeding that can lead to death.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.